Adult Congenital Heart Disease Guideline
The 2018 Adult Congenital Heart Disease (ACHD) guideline is a full revision of the "2008 ACC/AHA Guidelines for the Management of Adults with Congenital Heart Disease", which was the first U.S. guideline to be published on the topic. ACHD prevalence is growing due to the success of pediatric cardiology and congenital cardiac surgery in diagnosing and treating congenital heart defects in children. Improved survival to adulthood is most striking for those with the most severe disease, with survival to age 18 now expected for 90% of children diagnosed with severe congenital heart disease (CHD). This guideline is not intended to apply to children (<18 years of age) with CHD or adults with acquired valvular heart disease, heart failure, or other cardiovascular diseases.
Central Illustration: 2018 AHA/ACC Guideline for the Management of Adults with Congenital Heart Disease
- Shunt Lesions, Atrial Septal Defect, Ventricular Septal Defect, Coarctation of the Aorta, Tetralogy of Fallot, Transposition of the Great Arteries, Coronary Anomalies, Ebstein Anomaly, Congenital Valvular Aortic Stenosis